Amplifier Therapeutics

AM Pharma

This biopharmaceutical company develops recombinant human alkaline phosphatase therapeutics to treat patients suffering from sepsis-associated acute kidney injury and other severe inflammatory conditions.

Amphista Therapeutics

This company develops targeted protein degradation medicines to treat patients with cancer and other diseases.

BioAge Labs

This company develops therapeutic drugs targeting the biology of human aging to treat patients with metabolic and cardiovascular diseases.

Nitrase Therapeutics

This biopharmaceutical company develops enzyme-targeting therapies for patients with Parkinson's disease, cancer, and other age-related conditions.

Deciduous Therapeutics

This company develops small-molecule immunotherapies that activate the immune system to remove senescent cells for patients with age-related, metabolic and fibrotic diseases.

Amprologix

This biotechnology company develops novel antibiotics to treat antimicrobial-resistant bacterial infections for patients with conditions including MRSA and related skin and wound infections.

Samsara Therapeutics

This company develops autophagy-activating small molecule therapeutics to treat neurodegenerative and age-related diseases for patients with conditions such as ALS and Parkinson’s.

Amplifyer Bio

This company develops humanised priming agents that increase circulating tumour DNA recovery to improve liquid biopsy sensitivity for cancer diagnostic providers.